What is he best known for?
The fields of study he is best known for:
- Immune system
- Bacteria
- Amino acid
His primary areas of study are Cell biology, Tetraspanin, Cell adhesion, Molecular biology and Intercellular Adhesion Molecule-1.
Peter N. Monk has researched Cell adhesion in several fields, including Endothelial stem cell, Cell migration, Cell adhesion molecule and Transmembrane protein.
The study incorporates disciplines such as Amino acid and Binding site in addition to Molecular biology.
Peter N. Monk works mostly in the field of Amino acid, limiting it down to concerns involving COS cells and, occasionally, CD81.
His study in Binding site is interdisciplinary in nature, drawing from both Protein G and G protein.
Peter N. Monk has researched Intercellular Adhesion Molecule-1 in several fields, including Lipid raft, Integrin, Actin cytoskeleton and Cell membrane.
His most cited work include:
- Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81 (453 citations)
- CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. (330 citations)
- Function, structure and therapeutic potential of complement C5a receptors (297 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Cell biology, Receptor, C5a receptor, Tetraspanin and Biochemistry.
His Cell biology research incorporates themes from Endothelial stem cell and Cell activation.
The concepts of his Receptor study are interwoven with issues in Anaphylatoxin, Complement system and Transfection.
His C5a receptor study integrates concerns from other disciplines, such as 5-HT5A receptor, Complement C5a, Molecular biology, G protein and Binding site.
His Tetraspanin study incorporates themes from Cell adhesion, CD81, Cell fusion and Transmembrane protein.
His study explores the link between Cell adhesion and topics such as Intercellular Adhesion Molecule-1 that cross with problems in Cell migration.
He most often published in these fields:
- Cell biology (41.55%)
- Receptor (31.69%)
- C5a receptor (24.65%)
What were the highlights of his more recent work (between 2013-2021)?
- Cell biology (41.55%)
- Tetraspanin (24.65%)
- Microbiology (7.75%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cell biology, Tetraspanin, Microbiology, Receptor and Immunology.
The Cell biology study combines topics in areas such as Cytotoxic T cell, Innate immune system and Cell adhesion.
In his works, Peter N. Monk performs multidisciplinary study on Tetraspanin and CRISPR.
His research in Receptor intersects with topics in Cell, C5a receptor, Anaphylatoxin, Complement system and Flow cytometry.
His C5a receptor study combines topics from a wide range of disciplines, such as Arrestin, Complement C5a and Peptide.
In CD81, Peter N. Monk works on issues like Conserved sequence, which are connected to Molecular biology.
Between 2013 and 2021, his most popular works were:
- T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells (222 citations)
- Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling (42 citations)
- C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitment. (40 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Bacteria
- Genetics
Peter N. Monk spends much of his time researching Cell biology, Tetraspanin, Receptor, Cell and Glycosaminoglycan.
Peter N. Monk has included themes like Integrin, beta 6, Integrin, Cell adhesion and Cytotoxic T cell in his Cell biology study.
His research integrates issues of CD81, Conserved sequence, Molecular biology, Cell fusion and Giant cell in his study of Tetraspanin.
His Receptor research is multidisciplinary, relying on both C5a receptor and Complement system.
His C5a receptor research focuses on subjects like Arrestin, which are linked to Immunology.
His Cell research is multidisciplinary, incorporating perspectives in IC50, Flow cytometry and Heparin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
